On May 10, 2020, vice secretary of municipal party committee, the mayor of dongying zhi-yuan zhao, dongying port economic development zone, secretary of the working committee, management committee director Yang Tongxian party working committee of dongying port development zone, binhai xin-sheng wang, director of the party secretary of fine chemical industrial park, accompanied by shandong way combined medicine group chairman Song Weiguo in Shanghai zhangjiang science city's investment promotion and capital introduction work, We have inspected Shanghai Zhangjiang Kangqiao Industrial Park, Shanghai Tianci International Pharmaceutical Co., Ltd., and Japan Otsuka (China) Investment Co., Ltd., and negotiated and promoted the innovative drug pilot test base and innovative API Dongying Industrial Base undertaken by Doye Pharma Technology Co., Ltd.

      Accompanied by day kind pharmaceutical general manager to Marcy, visited the Shanghai day kind international pharmaceutical co., LTD. - day goodness "kechuang dreamworks", the project construction area of 280000 square meters, a total of 20 standard factory building, carry a maximum of 80 GMP production line, is day international according to market needs, the innovation of the integration of research and development, production, marketing resources to build sharing platform. Xilai Ma introduced the production, market, management and culture of the company in detail, and had an in-depth discussion on the cooperation in the industrialization of innovative drug APIs.

   During the meeting, Mayor Zhao Zhiyuan had a discussion with Wu Qiang, full-time deputy director of Shanghai Office of Advancing Science and Technology Innovation Center Construction and deputy director of Shanghai Zhangjiang High-tech Industrial Development Zone Management Committee, which further deepened the understanding of economic, social and industrial development between the two places. The next step will be to accelerate the signing of cooperation projects. Dongying Hong Kong Biomedical Industrial Park will deeply participate in the national innovative drug industry chain, stimulate the "chain" effect, realize the integration with the innovation chain and industrial chain system of Shanghai Zhangjiang Biomedical, and create a world-class platform for the sharing of innovative drug APIs.